264 related articles for article (PubMed ID: 21785908)
1. Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study.
Isaksen T; Nielsen CS; Christensen SE; Nissen PH; Heickendorff L; Mosekilde L
Calcif Tissue Int; 2011 Oct; 89(4):285-94. PubMed ID: 21785908
[TBL] [Abstract][Full Text] [Related]
2. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
[TBL] [Abstract][Full Text] [Related]
3. Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.
Vargas-Poussou R; Mansour-Hendili L; Baron S; Bertocchio JP; Travers C; Simian C; Treard C; Baudouin V; Beltran S; Broux F; Camard O; Cloarec S; Cormier C; Debussche X; Dubosclard E; Eid C; Haymann JP; Kiando SR; Kuhn JM; Lefort G; Linglart A; Lucas-Pouliquen B; Macher MA; Maruani G; Ouzounian S; Polak M; Requeda E; Robier D; Silve C; Souberbielle JC; Tack I; Vezzosi D; Jeunemaitre X; Houillier P
J Clin Endocrinol Metab; 2016 May; 101(5):2185-95. PubMed ID: 26963950
[TBL] [Abstract][Full Text] [Related]
4. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
[TBL] [Abstract][Full Text] [Related]
5. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Brixen K; Mosekilde L
Clin Endocrinol (Oxf); 2008 Nov; 69(5):713-20. PubMed ID: 18410554
[TBL] [Abstract][Full Text] [Related]
6. Increased trabecular volumetric bone mass density in Familial Hypocalciuric Hypercalcemia (FHH) type 1: a cross-sectional study.
Jakobsen NF; Rolighed L; Moser E; Nissen PH; Mosekilde L; Rejnmark L
Calcif Tissue Int; 2014 Aug; 95(2):141-52. PubMed ID: 24894639
[TBL] [Abstract][Full Text] [Related]
7. Familial hypocalciuric hypercalcemia in an index male: grey zones of the differential diagnosis from primary hyperparathyroidism in a 13-year clinical follow up.
Zajíčková K; Dvořáková M; Moravcová J; Včelák J; Goltzman D
Physiol Res; 2020 Sep; 69(Suppl 2):S321-S328. PubMed ID: 33094630
[TBL] [Abstract][Full Text] [Related]
8. Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.
Marx SJ
J Bone Miner Res; 2018 Jan; 33(1):27-31. PubMed ID: 29115694
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation of the calcium-sensing receptor gene in a German subject with familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Papadakis M; Meurer N; Margariti T; Meyer A; Weyerbrock N; Dotzenrath C
Hormones (Athens); 2016 Oct; 15(4):557-559. PubMed ID: 28222409
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density in patients with familial hypocalciuric hypercalcaemia (FHH).
Abugassa S; Nordenström J; Järhult J
Eur J Surg; 1992 Aug; 158(8):397-402. PubMed ID: 1356477
[TBL] [Abstract][Full Text] [Related]
11. Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
Clin Endocrinol (Oxf); 2009 Dec; 71(6):798-807. PubMed ID: 19250271
[TBL] [Abstract][Full Text] [Related]
12. Familial hypocalciuric hypercalcaemia: a review.
Christensen SE; Nissen PH; Vestergaard P; Mosekilde L
Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):359-70. PubMed ID: 21986511
[TBL] [Abstract][Full Text] [Related]
13. Muscle function and quality of life are not impaired in familial hypocalciuric hypercalcemia: a cross-sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene (CASR).
Jakobsen NF; Rolighed L; Nissen PH; Mosekilde L; Rejnmark L
Eur J Endocrinol; 2013 Sep; 169(3):349-57. PubMed ID: 23764372
[TBL] [Abstract][Full Text] [Related]
14. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report.
Marstrand SD; Tofteng CL; Jarløv A; Borgwardt L; Schwarz P
J Med Case Rep; 2021 Sep; 15(1):471. PubMed ID: 34556169
[TBL] [Abstract][Full Text] [Related]
15. Misleading localization by
Mukhtar NN; Abouzied MEM; Alqahtani MH; Hammami MM
BMC Endocr Disord; 2021 Jan; 21(1):20. PubMed ID: 33499837
[TBL] [Abstract][Full Text] [Related]
16. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.
Guarnieri V; Canaff L; Yun FH; Scillitani A; Battista C; Muscarella LA; Wong BY; Notarangelo A; D'Agruma L; Sacco M; Cole DE; Hendy GN
J Clin Endocrinol Metab; 2010 Apr; 95(4):1819-29. PubMed ID: 20164288
[TBL] [Abstract][Full Text] [Related]
17. Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism.
Frank-Raue K; Leidig-Bruckner G; Haag C; Schulze E; Lorenz A; Schmitz-Winnenthal H; Raue F
Clin Endocrinol (Oxf); 2011 Jul; 75(1):50-5. PubMed ID: 21521328
[TBL] [Abstract][Full Text] [Related]
18. Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism.
Shinall MC; Dahir KM; Broome JT
Endocr Pract; 2013; 19(4):697-702. PubMed ID: 23425644
[TBL] [Abstract][Full Text] [Related]
19. Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review.
Zahedi M; Hizomi Arani R; Rafati M; Amouzegar A; Hadaegh F
BMC Endocr Disord; 2021 Nov; 21(1):220. PubMed ID: 34736428
[TBL] [Abstract][Full Text] [Related]
20. Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia.
Bertocchio JP; Tafflet M; Koumakis E; Maruani G; Vargas-Poussou R; Silve C; Nissen PH; Baron S; Prot-Bertoye C; Courbebaisse M; Souberbielle JC; Rejnmark L; Cormier C; Houillier P
J Clin Endocrinol Metab; 2018 Jul; 103(7):2534-2542. PubMed ID: 29727008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
